Free Trial

Basilea Pharmaceutica (BPMUF) Short Interest Ratio & Short Volume

→ Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad)
Free BPMUF Stock Alerts
$48.15
0.00 (0.00%)
(As of 05/21/2024 ET)
Compare
Stock AnalysisChartHeadlinesShort Interest

Basilea Pharmaceutica Short Interest Data

Current Short Interest
85,300 shares
Previous Short Interest
209,600 shares
Change Vs. Previous Month
-59.30%
Dollar Volume Sold Short
$3.79 million
Short Interest Ratio
0.0 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
11,850,000 shares
Percentage of Shares Shorted
0.72%
Today's Trading Volume
0 shares
Average Trading Volume
0 shares
Today's Volume Vs. Average
NaN
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Basilea Pharmaceutica ?

Sign up to receive the latest short interest report for Basilea Pharmaceutica and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

BPMUF Short Interest Over Time

BPMUF Days to Cover Over Time

BPMUF Percentage of Float Shorted Over Time

Basilea Pharmaceutica Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202485,300 shares $3.79 million -59.3%N/A0 $44.45
4/15/2024209,600 shares $9.32 million -6.5%N/A2096 $44.45
3/31/2024224,100 shares $9.13 million +0.6%N/A0 $40.75
3/15/2024222,800 shares $9.08 million +3.3%N/A0 $40.75
2/29/2024215,600 shares $8.79 million -14.3%N/A0 $40.75
2/15/2024251,600 shares $10.25 million -9.1%N/A2516 $40.75
1/15/2024268,800 shares $11.02 million +3.0%N/A0 $41.00
12/31/2023260,900 shares $10.70 million +1.5%N/A0 $41.00
12/15/2023257,100 shares $10.54 million +2.0%N/A0 $41.00
11/30/2023252,100 shares $10.34 million -1.9%N/A0 $41.00
11/15/2023256,900 shares $10.53 million -0.7%N/A0 $41.00
10/31/2023258,800 shares $10.61 million -9.0%N/A2588 $41.00
10/15/2023284,400 shares $14.22 million -1.4%N/A0 $50.00
9/30/2023288,300 shares $14.42 million +7.5%N/A0 $50.00
9/15/2023268,300 shares $13.42 million -2.9%N/A0 $50.00
8/31/2023276,400 shares $13.82 million -9.2%N/A0 $50.00
8/15/2023304,300 shares $15.22 million +2.6%N/A0 $50.00
7/31/2023296,600 shares $14.83 million -12.1%N/A0 $50.00
7/15/2023337,300 shares $16.87 million -2.9%N/A0 $50.00
6/30/2023347,200 shares $17.36 million +4.0%N/A0 $50.00
6/15/2023333,900 shares $16.70 million -1.6%N/A3339 $50.00
5/31/2023339,200 shares $16.96 million +0.6%N/A3392 $50.00
5/15/2023337,300 shares $17.54 million -14.7%N/A3373 $52.00
4/30/2023395,600 shares $20.57 million +0.4%N/A0 $52.00
4/15/2023394,000 shares $20.49 million +0.5%N/A0 $52.00
3/31/2023392,200 shares $20.39 million +5.5%N/A0 $52.00
3/15/2023371,700 shares $19.33 million +0.5%N/A0 $52.00
2/28/2023369,700 shares $19.22 million -4.5%N/A0 $52.00
2/15/2023386,900 shares $20.12 million +3.6%N/A0 $52.00
1/31/2023373,400 shares $19.42 million +1.3%N/A0 $52.00
1/15/2023368,800 shares $19.18 million -0.1%N/A0 $52.00
12/30/2022369,000 shares $19.19 million +0.2%N/A0 $52.00
12/15/2022368,300 shares $19.15 million -0.9%N/A0 $52.00
11/30/2022371,800 shares $19.33 million -2.2%N/A3718 $52.00
11/15/2022380,200 shares $17.49 million -0.1%N/A3802 $46.00
10/31/2022380,600 shares $15.60 million -3.7%N/A0 $41.00
10/15/2022395,100 shares $16.20 million -2.7%N/A0 $41.00
9/30/2022406,100 shares $16.65 million +0.5%N/A0 $41.00
9/15/2022404,200 shares $16.57 million +6.2%N/A4042 $41.00
8/31/2022380,700 shares $15.61 million -5.5%N/A0 $41.00
Everybody laughed when he recommended Netflix (Ad)

"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined.

Click here to see how it could become the No. 1 investment of the next decade.
8/15/2022402,900 shares $16.52 million -21.8%N/A0 $41.00
7/31/2022515,400 shares $21.13 million -19.0%N/A0 $41.00
7/15/2022635,900 shares $26.07 million -1.9%N/A0 $41.00
6/30/2022648,000 shares $26.57 million -1.3%N/A0 $41.00
6/15/2022656,300 shares $26.91 million -2.0%N/A0 $41.00
5/31/2022669,900 shares $27.47 million -0.6%N/A0 $41.00
5/15/2022673,600 shares $27.62 million -0.3%N/A0 $41.00
4/30/2022675,600 shares $27.70 million +2.3%N/A0 $41.00
4/15/2022660,500 shares $27.08 million +4.2%N/A0 $41.00
3/31/2022634,000 shares $25.99 million -2.3%N/A0 $41.00
3/15/2022649,000 shares $26.61 million -1.2%N/A0 $41.00
2/28/2022656,900 shares $26.93 million +4.5%N/A0 $41.00
2/15/2022628,900 shares $25.78 million +0.5%N/A6289 $41.00
1/31/2022625,900 shares $25.66 million -1.2%N/A0 $41.00
1/15/2022633,200 shares $25.96 million -1.1%N/A0 $41.00
12/31/2021640,000 shares $26.24 million -2.8%N/A0 $41.00
12/15/2021658,300 shares $26.99 million +0.6%N/A6583 $41.00
11/30/2021654,300 shares $30.75 million +1.8%N/A0 $47.00
11/15/2021642,500 shares $30.20 million +17.1%N/A0 $47.00
10/29/2021548,700 shares $25.79 million +8.0%N/A0 $47.00
10/15/2021508,100 shares $23.88 million +0.8%N/A5081 $47.00
9/30/2021504,000 shares $23.18 million +5.1%N/A0 $46.00
9/15/2021479,400 shares $22.05 million -3.3%N/A0 $46.00
8/31/2021495,700 shares $22.80 million -4.1%N/A0 $46.00
8/13/2021516,600 shares $23.76 million -2.7%N/A0 $46.00
7/30/2021530,800 shares $24.42 million -6.3%N/A5308 $46.00
7/15/2021566,400 shares $28.21 million -1.7%N/A0 $49.80
6/30/2021576,400 shares $28.71 million -1.1%N/A5764 $49.80
6/15/2021582,600 shares $26.82 million -2.5%N/A0 $46.04
5/28/2021597,800 shares $27.52 million +0.7%N/A0 $46.04
5/14/2021593,500 shares $26.74 million -1.1%N/A5935 $45.05
4/30/2021600,100 shares $31.14 million -0.6%N/A6001 $51.89
4/15/2021603,400 shares $30.29 million -2.6%N/A6034 $50.20
3/31/2021619,400 shares $30.85 million -0.9%N/A6194 $49.80
3/15/2021625,200 shares $31.99 million +10.1%N/A6252 $51.16
2/26/2021567,800 shares $32.93 million +1.7%N/A5678 $58.00
2/12/2021558,100 shares $33.21 million +0.9%N/A0 $59.50
1/29/2021553,100 shares $32.91 million +0.9%N/A0 $59.50
1/15/2021550,300 shares $32.17 million -1.9%N/A5503 $58.46
12/31/2020548,800 shares $33.11 million -0.3%N/A5488 $60.34
12/15/2020550,300 shares $32.63 million -1.9%N/A5503 $59.30
11/30/2020560,800 shares $33.31 million -2.9%N/A5608 $59.40
11/15/2020577,400 shares $31.18 million +2.0%N/A0 $54.00
10/30/2020566,000 shares $30.56 million +13.8%N/A5660 $54.00
10/15/2020497,200 shares $27.15 million -4.9%N/A4972 $54.60
9/30/2020522,600 shares $29.01 million -1.3%N/A0 $55.52
9/15/2020529,300 shares $29.39 million -1.0%N/A5293 $55.52
8/31/2020534,500 shares $29.68 million -2.5%N/A2672.5 $55.52
8/14/2020548,300 shares $30.41 million +5.9%N/A0 $55.47
7/31/2020517,800 shares $28.88 million +64.0%N/A0 $55.77
Everybody laughed when he recommended Netflix (Ad)

"This Could be Worth Even More than A.I." Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined.

Click here to see how it could become the No. 1 investment of the next decade.
7/15/2020315,800 shares $17.61 million +0.9%N/A3158 $55.77
6/30/2020313,000 shares $15.89 million -1.2%N/A3130 $50.78
6/15/2020316,700 shares $16.66 million -1.6%N/A0 $52.60
5/29/2020321,700 shares $15.96 million -16.7%N/A3217 $49.60
5/15/2020386,400 shares $19.52 million -1.5%N/A0 $50.51
4/30/2020392,100 shares $19.80 million +4.1%N/A3921 $50.51
4/15/2020376,500 shares $18.84 million +0.2%N/A3765 $50.03
3/31/2020375,800 shares $14.00 million -18.6%N/A3758 $37.25
3/13/2020461,900 shares $20.46 million -13.7%N/A4619 $44.30
2/28/2020535,100 shares $23.70 million +5.0%N/A0 $44.30
2/14/2020509,500 shares $22.57 million -0.4%N/A0 $44.30
1/31/2020511,400 shares $30.48 million -0.6%N/A5114 $59.60
1/15/2020514,400 shares $30.66 million +1.5%N/A5144 $59.60
12/31/2019506,600 shares $30.19 million -2.1%N/A0 $59.60

BPMUF Short Interest - Frequently Asked Questions

What is Basilea Pharmaceutica's current short interest?

Short interest is the volume of Basilea Pharmaceutica shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 85,300 shares of BPMUF short. Learn More on Basilea Pharmaceutica's current short interest.

Is Basilea Pharmaceutica's short interest increasing or decreasing?

Basilea Pharmaceutica saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 85,300 shares, a decline of 59.3% from the previous total of 209,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Basilea Pharmaceutica's short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Basilea Pharmaceutica: KalVista Pharmaceuticals, Inc. (13.13%), Applied Therapeutics, Inc. (3.91%), Verve Therapeutics, Inc. (30.19%), Astria Therapeutics, Inc. (10.24%), Y-mAbs Therapeutics, Inc. (7.47%), Aerovate Therapeutics, Inc. (10.43%), Arbutus Biopharma Co. (3.08%), IGM Biosciences, Inc. (29.87%), Travere Therapeutics, Inc. (16.83%), Larimar Therapeutics, Inc. (6.11%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Basilea Pharmaceutica stock?

Short selling BPMUF is an investing strategy that aims to generate trading profit from Basilea Pharmaceutica as its price is falling. BPMUF shares are trading up $3.70 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Basilea Pharmaceutica?

A short squeeze for Basilea Pharmaceutica occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BPMUF, which in turn drives the price of the stock up even further.

How often is Basilea Pharmaceutica's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BPMUF, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

Related Companies:
Short Interest Tools:
This page (OTCMKTS:BPMUF) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners
The ONE AI Stock to own now. (It’s not Nvidia.)
Weiss Ratings
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders
Biden Nomination CANCELED?
The Freeport Society
Write this ticker symbol down…
StocksToTrade
Shocking $16T Elon Musk Crypto Leak
Crypto 101 Media
Claim Your Complimentary Bitcoin Reward
Crypto Swap Profits
Warren Buffett's "mystery stock"
Stansberry Research
This Could be Your “Big Money” AI Moment
InvestorPlace